Evidence map›Paper›PMID 31784794›Full record

ArticleDer Orthopade2020

[Effects and sustainability of knee school : 2-year results of a secondary prevention program for gonarthrosis].

Aki Pietsch, Jan Schröder, Karsten Hollander, Helge Riepenhof

Abstract read
PubMed Publisher
In one paragraph

Article in Der Orthopade, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aki PietschSportprävention, Sportrehabilitation, BG Klinikum Hamburg, Hamburg, Deutschland. a.pietsch@bgk-hamburg.de.
Jan SchröderArbeitsbereich Sport- und Bewegungsmedizin, Institut für Bewegungswissenschaft, Universität Hamburg, Hamburg, Deutschland.
Karsten HollanderSportprävention, Sportrehabilitation, BG Klinikum Hamburg, Hamburg, Deutschland.
Helge RiepenhofSportprävention, Sportrehabilitation, BG Klinikum Hamburg, Hamburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCraftsmen and workers in the construction industry are at an increased risk of developing gonarthrosis due to their work-related burdens. In order to maintain the ability to work, occupational co-operative measures for secondary prevention can be carried out (BG Bau/Kniekolleg). The aim was to evaluate the efficacy after 2 years, depending on the degree of exercise adherence. MATERIAL AND

methodsIn a repeated measurement design (T1 before, T2 after knee school, T3 after 1 year, T4 after 2 years), 140 construction patients were assessed for their dynamic muscular strength (knee extension, 60°/s,); their quality of life (SF-36) and characteristics for gonarthrosis (WOMAC) were evaluated using analyses of variances, whereby one group trained after the knee training in the gym with instruction (Gr. 1 n = 63), one group completed a home-training program (Gr. 2 n = 38), and one group completed exercises outside of knee school (Gr.3 n = 39).

resultsFor all parameters, significant acute efficacy and 2‑year sustainability effects were observed (p ≤ 0.05, d: 0.2-0.8). There was no interaction with adherence during training after knee school (p > 0.05).

conclusionKnee school has proved to be effective in the long term, leading to a critical questioning of future research, why there are no differences between guided, reduced or even missing long-term maintenance training.

Indexed as

Exercise TherapyQuality of LifeHumansKnee JointMuscle StrengthOccupational DiseasesOccupational HealthOsteoarthritis, KneeSecondary PreventionMotivationMultimodal treatmentOsteoarthritis, kneePhysical activityPreventive medicine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.